|
Dr. Richard Ascione is currently a consultant and Equity Investment Advisor to several Wall Street Companies as an Industry Expert. Prior to this activity Dr. Ascione served more than 10 years in the Biotech Industry as the Vice President, Research, Aphton Corporation, and Director of their Laboratory of Molecular Medicine working on the development of Cancer Vaccine for GI malignancy. Previously, Dr. Ascione was a tenured professor in the Department of Experimental Oncology and Associate Director of the Center for Molecular and Structural Biology at the Hollings Cancer Center and the Medical University of South Carolina, respectively, in Charleston, South Carolina. Earlier, Dr. Ascione was with the National Cancer Institute (NCI) of the National Institutes of Health (NIH), where he served as Deputy Chief of NCI's Laboratory of Molecular Oncology for more than 20 years. Dr. Ascione has published over seventy peer-reviewed papers, including several book chapters and articles related to molecular medicine, virology and the gene regulation of cancer, human retroviruses and HIV/AIDS. | 